Conservative treatment of distal rectal cancer by local excision.

Abstract:

:From 1954 through 1982, 57 patients with invasive, distal rectal cancer had a full-thickness local excision with curative intent. Prognostic criteria and need for further treatment were based on the histopathologic results of the operative specimen. The overall 5-year survival rate was 83.4%. The rectal cancer-specific mortality rate was 10.5%. None of the 27 patients without adverse prognostic factors died from rectal cancer, and for this group local excision alone was sufficient treatment. The only single factors associated with an adverse outcome were mucinous characteristics and full-thickness invasion. Ulceration alone and penetration into the muscularis propria alone were not adverse factors. In the presence of multiple adverse prognostic factors, mucinous characteristics or full-thickness penetration, local excision was inadequate treatment and an abdominal perineal resection was necessary.

journal_name

Cancer

journal_title

Cancer

authors

DeCosse JJ,Wong RJ,Quan SH,Friedman NB,Sternberg SS

doi

10.1002/1097-0142(19890115)63:2<219::aid-cncr28206

subject

Has Abstract

pub_date

1989-01-15 00:00:00

pages

219-23

issue

2

eissn

0008-543X

issn

1097-0142

journal_volume

63

pub_type

杂志文章

相关文献

CANCER文献大全
  • Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.

    abstract:BACKGROUND:Aberrant expression of the facilitative glucose transporter, GLUT1, is found in a wide spectrum of epithelial malignancies. The current study describes an immunohistochemical study of GLUT1 expression in benign, hyperplastic, and malignant endometrial epithelia. METHODS:One hundred sixteen formalin fixed, p...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Wang BY,Kalir T,Sabo E,Sherman DE,Cohen C,Burstein DE

    更新日期:2000-06-15 00:00:00

  • Undifferentiated (embryonal) sarcoma of the liver. Epithelial features as shown by immunohistochemical analysis and electron microscopic examination.

    abstract::The cell differentiation properties of two undifferentiated (embryonal) sarcomas of the liver (USL), one in a 9-year-old boy and one in a 23-year-old man, were studied by immunohistochemistry and electron microscopic examination. Both tumors showed a part pleomorphic pattern and a part myxoid spindle cell sarcomatous ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891115)64:10<2096::aid-cncr282

    authors: Miettinen M,Kahlos T

    更新日期:1989-11-15 00:00:00

  • Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer.

    abstract:BACKGROUND:Breast cancer is the second most common source of brain metastasis. Stereotactic radiosurgery (SRS) can be an effective treatment for some patients with brain metastasis (BM). Necrosis is a common feature of many brain tumors, including BM; however, the influence of tumor necrosis on treatment efficacy of SR...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26314

    authors: Xu Z,Marko NF,Angelov L,Barnett GH,Chao ST,Vogelbaum MA,Suh JH,Weil RJ

    更新日期:2012-03-01 00:00:00

  • Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.

    abstract:BACKGROUND:CD133 is a specific surface marker for bone marrow-derived circulating endothelial progenitors, which are vital in postnatal physiologic and pathologic (eg, tumor) angiogenesis. In this study, the authors examined whether increased levels of expression of CD133 messenger RNA (mRNA) in peripheral blood predic...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22774

    authors: Lin EH,Hassan M,Li Y,Zhao H,Nooka A,Sorenson E,Xie K,Champlin R,Wu X,Li D

    更新日期:2007-08-01 00:00:00

  • Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.

    abstract:BACKGROUND:A National Institutes of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of b...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Lazovich D,Solomon CC,Thomas DB,Moe RE,White E

    更新日期:1999-08-15 00:00:00

  • The value of splenectomy in chronic lymphocytic leukemia.

    abstract::Between January 1, 1980, and July 31, 1985, 168 patients were treated at our institution for chronic lymphocytic leukemia (CLL). Splenectomy was performed on 32 (23 men and 9 women). The mean age of these surgical patients was 59.4 years (range, 43-75). Twenty-four patients had received chemotherapy and/or corticother...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870115)59:2<340::aid-cncr28205

    authors: Delpero JR,Gastaut JA,Letreut YP,Caamano A,Mathieu-Tubiana N,Maraninchi D,Simon-Lejeune C,Mascret B,Blanc AP,Sebahoun G

    更新日期:1987-01-15 00:00:00

  • Tumor-associated antigen 43-9F is of prognostic value in squamous cell carcinoma of the lung. A retrospective immunohistochemical study.

    abstract:BACKGROUND:Squamous cell lung carcinoma (SLC), the most frequent type of lung cancer, generally is treated surgically and its prognosis is poor. The only current clinically useful prognostic criterion is lymph node staging (TNM classification). Expression of a novel tumor-associated carbohydrate epitope Gal beta 1-3[Fu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19921001)70:7<1867::aid-cncr2820

    authors: Battifora H,Sorensen HR,Mehta P,Ahn C,Niland J,Hage E,Pettijohn DE,Olsson L

    更新日期:1992-10-01 00:00:00

  • Mental neuropathy (numb chin syndrome). A harbinger of tumor progression or relapse.

    abstract::The authors report four patients whose initial symptom of tumor recurrence or progression was unilateral numbness of the chin. Two patients had Hodgkin lymphoma, one had malignant melanoma, and one had prostate cancer. Physical examination was notable only for unilateral anesthesia of the chin and lower lip. Diagnosti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920815)70:4<877::aid-cncr28207

    authors: Burt RK,Sharfman WH,Karp BI,Wilson WH

    更新日期:1992-08-15 00:00:00

  • Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patien

    abstract:BACKGROUND:The prognostic relevance of activated oncogenes and oncoproteins has not been well studied in papillary thyroid cancer, which is slow-growing, with only regional spread in most cases. Therefore, the influence of some protein markers and tumor cell proliferation on disease progress in a series of patients wit...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19951101)76:9<1643::aid-cncr2820

    authors: Akslen LA,Varhaug JE

    更新日期:1995-11-01 00:00:00

  • Systemic aspergillosis as cause of myocardial infarction.

    abstract::Systemic aspergillosis is encountered with increasing prevalence in immunocompromised patients undergoing chemotherapy. The current communication describes the clinical and postmortem findings in three leukemic patients who developed myocardial infarction secondary to Aspergillus embolization of the coronary arteries....

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19861101)58:9<2146::aid-cncr2820

    authors: Andersson BS,Luna MA,McCredie KB

    更新日期:1986-11-01 00:00:00

  • Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.

    abstract:BACKGROUND:Reliable predictive biomarkers are required to address the challenge of disease recurrence after thyroid cancer surgery. For this study, the authors assessed the association of cellular-based and serum-based immunologic mediators with thyroid cancer recurrence. METHODS:Leukocyte subset counts and immune reg...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27937

    authors: Owonikoko TK,Hossain MS,Bhimani C,Chen Z,Kim S,Ramalingam SS,Sun SY,Shin DM,Waller EK,Khuri FR

    更新日期:2013-04-15 00:00:00

  • Occupation and lung cancer risk. An analysis by histologic subtypes.

    abstract::The relationships between cigarette smoking, occupational exposures, dietary vitamin A and lung cancer is explored in a case-control study. The study is based on 1002 primary lung cancers among white men and 1119 white male controls between 35 and 79 years of age admitted to Roswell Park Memorial Institute from 1957 t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850815)56:4<910::aid-cncr28205

    authors: Vena JE,Byers TE,Cookfair D,Swanson M

    更新日期:1985-08-15 00:00:00

  • Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.

    abstract:BACKGROUND:Early stage lung cancer has a variable prognosis, and there are currently no markers that predict which patients will recur. This study examined the relation between tumor-regulatory T (Treg) cells and total tumor-infiltrating T-cell lymphocytes (TIL) to determine whether they correlated with recurrence. ME...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22282

    authors: Petersen RP,Campa MJ,Sperlazza J,Conlon D,Joshi MB,Harpole DH Jr,Patz EF Jr

    更新日期:2006-12-15 00:00:00

  • Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.

    abstract:BACKGROUND:The expression of vascular endothelial growth factor (VEGF)-A isoforms (121, 165, 189, 206), VEGF-B, VEGF-C and VEGF-D in both experimental and clinical models of head and neck squamous cell carcinoma (HNSCC) was determined and correlated with conventional clinicopathologic parameters, with particular refere...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010801)92:3<556::aid-cncr1355>

    authors: O-charoenrat P,Rhys-Evans P,Eccles SA

    更新日期:2001-08-01 00:00:00

  • Hemangioendothelioma with intravascular coagulation and ischemic colitis.

    abstract::An infant who presented with a thigh mass and coagulopathy was found to have a hemangioendothelioma. The tumor rapidly enlarged despite accepted therapeutic modalities, and the child died after a sudden cardiac arrest. Postmortem examination revealed a highly invasive tumor mass that had infiltrated the bowel and invo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841115)54:10<2300::aid-cncr282

    authors: Weinblatt ME,Kahn E,Kochen JA

    更新日期:1984-11-15 00:00:00

  • Improved accuracy in differentiating malignant from benign mammographic abnormalities: a simple, improved magnetic resonance imaging method.

    abstract:BACKGROUND:Although several refinements have been reported for breast magnetic resonance imaging (MRI), there has been no uniform agreement by researchers on the optimal method. The authors report a simple and effective MRI method that incorporated the best qualities of other breast MRI methods yet eliminated the compl...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010801)92:3<471::aid-cncr1345>

    authors: Khatri VP,Stuppino JJ,Espinosa MH,Pollack MS

    更新日期:2001-08-01 00:00:00

  • Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.

    abstract::Effective management of hepatic metastases from ocular and cutaneous melanoma remains a major therapeutic challenge. Treatment options include hepatic resection, hepatic intra-arterial (HIA) chemotherapy, chemoembolization, and hepatic perfusions. Evaluating the efficacy of these interventions is limited by the retros...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.28480

    authors: Agarwala SS,Eggermont AM,O'Day S,Zager JS

    更新日期:2014-03-15 00:00:00

  • Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.

    abstract:BACKGROUND:The carboplatin-based chemotherapeutic regimen M-CAVI (methotrexate, carboplatin, and vinblastine) is active against bladder carcinoma and can be administered to patients who are ineligible to receive cisplatin or doxorubicin. The authors designed a randomized study to evaluate whether M-CAVI offers a therap...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(sici)1097-0142(19971115)80:10<1966::aid-c

    authors: Bellmunt J,Ribas A,Eres N,Albanell J,Almanza C,Bermejo B,Solé LA,Baselga J

    更新日期:1997-11-15 00:00:00

  • Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy.

    abstract::Forty-nine patients with regionally confined recurrent malignancy were treated with intra-arterial cis-diamminedichloro platinum II in a Phase I-II trial. A safe starting dose of 120 mg/m2 was established. An overall response rate of 45% was noted with significant responses observed among patients with melanoma, sarco...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800315)45:6<1278::aid-cncr2820

    authors: Calvo DB 3rd,Patt YZ,Wallace S,Chuang VP,Benjamin RS,Pritchard JD,Hersh EM,Bodey GP Sr,Mavligit GM

    更新日期:1980-03-15 00:00:00

  • Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?

    abstract::In an article published in this issue of Cancer, D'Arcy et al link the incidence of cancer among recipients of solid organ transplantation (SOT) in the Scientific Registry of Transplant Recipients with data from regional and statewide cancer registries to examine cancer-specific mortality for common malignancies in SO...

    journal_title:Cancer

    pub_type: 评论,杂志文章

    doi:10.1002/cncr.31963

    authors: Koff JL,Waller EK

    更新日期:2019-03-15 00:00:00

  • Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.

    abstract:BACKGROUND:Immune checkpoint inhibitors (ICIs) represent an appealing treatment for patients with advanced urothelial cancer (aUC) and a poor performance status (PS). However, the benefit of ICIs for patients with a poor PS remains unknown. It was hypothesized that a poor Eastern Cooperative Oncology Group (ECOG) PS (≥...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.32645

    authors: Khaki AR,Li A,Diamantopoulos LN,Bilen MA,Santos V,Esther J,Morales-Barrera R,Devitt M,Nelson A,Hoimes CJ,Shreck E,Assi H,Gartrell BA,Sankin A,Rodriguez-Vida A,Lythgoe M,Pinato DJ,Drakaki A,Joshi M,Isaacsson Velho P

    更新日期:2020-03-15 00:00:00

  • Defining a molecular phenotype for benign and malignant parathyroid tumors.

    abstract:BACKGROUND:It is frequently difficult to establish histologically whether a parathyroid tumor is a parathyroid carcinoma, parathyromatosis, or an atypical adenoma. The authors asked whether these tumors have a distinctive molecular profile, whether benign tumors could be distinguished from malignant tumors, and whether...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24037

    authors: Fernandez-Ranvier GG,Khanafshar E,Tacha D,Wong M,Kebebew E,Duh QY,Clark OH

    更新日期:2009-01-15 00:00:00

  • A phase II study of bortezomib in the treatment of metastatic malignant melanoma.

    abstract:BACKGROUND:Bortezomib is a proteasome inhibitor with manageable clinical toxicity and laboratory evidence of anti-melanoma activity. Therefore, it was considered for clinical testing in patients with metastatic melanoma. METHODS:Patients with metastatic melanoma and adequate hematologic, renal, and hepatic function we...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.21108

    authors: Markovic SN,Geyer SM,Dawkins F,Sharfman W,Albertini M,Maples W,Fracasso PM,Fitch T,Lorusso P,Adjei AA,Erlichman C

    更新日期:2005-06-15 00:00:00

  • Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.

    abstract:BACKGROUND:In oligodendroglial tumors, allelic losses on chromosome arms 1p and 19q are not only diagnostic molecular markers but also statistically significant predictors of both chemosensitivity and longer recurrence-free survival. In the current study, the authors attempted to analyze 21 patients genetically and cli...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11322

    authors: Hashimoto N,Murakami M,Takahashi Y,Fujimoto M,Inazawa J,Mineura K

    更新日期:2003-05-01 00:00:00

  • Reversal of multidrug resistance to cancer chemotherapy.

    abstract::In the past few years, the role of membrane-bound transport genes in human disease has been increasingly recognized and understood. Of these genes, the p170 membrane glycoprotein may function as an outward transport pump for many cancer chemotherapeutic drugs associated with the multidrug resistance phenotype. This ar...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19931201)72:11+<3484::aid-cncr28

    authors: Leyland-Jones B,Dalton W,Fisher GA,Sikic BI

    更新日期:1993-12-01 00:00:00

  • Absence of V599E BRAF mutations in desmoplastic melanomas.

    abstract:BACKGROUND:Desmoplastic melanoma is an uncommon variant of cutaneous melanoma that mimics soft tissue sarcoma both clinically and morphologically. An activating point mutation of the BRAF oncogene has been identified in a high proportion of conventional cutaneous melanomas, but its frequency in the desmoplastic subtype...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20861

    authors: Davison JM,Rosenbaum E,Barrett TL,Goldenberg D,Hoque MO,Sidransky D,Westra WH

    更新日期:2005-02-15 00:00:00

  • Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.

    abstract::Correlations of c-erbB-2 protein expression with clinical outcomes of gastric carcinomas were studied in 189 gastric carcinomas. There were 23 (12.2%) carcinomas with evidence of c-erbB-2 protein in which the reaction was localized to the cell membrane. There was no significant association between c-erbB-2 staining an...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910601)67:11<2914::aid-cncr282

    authors: Yonemura Y,Ninomiya I,Ohoyama S,Kimura H,Yamaguchi A,Fushida S,Kosaka T,Miwa K,Miyazaki I,Endou Y

    更新日期:1991-06-01 00:00:00

  • Routine full-lung tomography in the initial staging and treatment planning of patients with Hodgkin's disease and non-Hodgkin's lymphoma.

    abstract::The yield of additional information from anteroposterior full-lung tomograms that changed stage or treatment, in comparison to that obtained from routine chest radiographs, was prospectively evaluated in 243 previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma. Although new information was f...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197609)38:3<1130::aid-cncr282038

    authors: Castellino RA,Filly R,Blank N

    更新日期:1976-09-01 00:00:00

  • Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database.

    abstract:BACKGROUND:Validation of the prognostic indices for the recurrence-free interval of patients with parotid carcinoma, the development of which was described in a previous report, is needed to be confident of their generalizability and justified prospective use. METHODS:The Dutch Cooperative Group on Head and Neck Cance...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11254

    authors: Vander Poorten VL,Hart AA,van der Laan BF,Baatenburg de Jong RJ,Manni JJ,Marres HA,Meeuwis CA,Lubsen H,Terhaard CH,Balm AJ

    更新日期:2003-03-15 00:00:00

  • Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial.

    abstract:BACKGROUND:The purpose of this study was to evaluate the feasibility, toxicity, and efficacy of the combination of paclitaxel, carboplatin, and long-term continuous infusion 5-fluorouracil (5-FU) in the treatment of advanced squamous carcinomas of various primary sites. METHODS:Patients were eligible for this trial if...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20010801)92:3<642::aid-cncr1365>

    authors: Hainsworth JD,Burris HA 3rd,Meluch AA,Baker MN,Morrissey LH,Greco FA

    更新日期:2001-08-01 00:00:00